What is the significance of these two HLA (Human Leukocyte Antigen) genotypes in determining compatibility for organ transplantation or assessing genetic predisposition to autoimmune diseases?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HLA Genotype Compatibility Assessment for Transplantation

The two HLA genotypes presented show significant mismatches at multiple loci, which would likely result in a high risk of rejection and graft failure in solid organ transplantation, particularly kidney transplantation where HLA-DQ matching is increasingly recognized as critical for long-term outcomes. 1

Analysis of HLA Mismatches Between the Two Genotypes

Class I HLA Antigens

  • Mismatches at HLA-A loci: A29:02:01:01/A03:01:01:01 vs. A01:01:01/A02:01P 1
  • Mismatches at HLA-B loci: B15:01:01:01/B44:03:01:01 vs. B38:01:01/B44:02:01 (note: B44:03 and B44:02 are different alleles of the B44 family) 1
  • Partial match at HLA-C loci: C16:01:01:01/C03:03:01:01 vs. C05:01:01/C12:03:01 1

Class II HLA Antigens

  • Partial match at HLA-DRB1: DRB104:04:01:14/DRB113:01:01:03 vs. DRB104:01:01G/DRB113:01P 1
  • Mismatches at HLA-DQB1: DQB104:04:01:14/DQB106:03:01:01 vs. DQB103:01:01/DQB106:03:01 1
  • Mismatches at HLA-DQA1: DQA103:01:01:01/DQA101:03:01:02 vs. DQA101:03:01/DQA103:03:01 1
  • Partial match at HLA-DPB1: DPB103:01/DPB104:01 vs. DPB102:01/DPB104:01 1

Clinical Significance in Transplantation

Kidney Transplantation

  • HLA-DQ mismatches significantly increase the risk of graft loss in both living and deceased donor kidney transplantation (HR 1.12) 1
  • HLA-DQ donor-specific antibodies (DSAs) are particularly strong, persistent, and resistant to treatment 1
  • Patients with 2 HLA-DQ mismatches in their first graft have >50% chance of becoming highly sensitized if they need retransplantation 1
  • The DQA1/DQB1 pairing (DQ heterodimer) is critical, as both chains contribute to immunogenicity 1

Hematopoietic Stem Cell Transplantation

  • High-resolution matching for HLA-A, -B, -C, and -DRB1 (8/8 match) is considered the gold standard 2
  • HLA-DQB1 matching has shown variable importance in recent studies 2
  • These genotypes show mismatches at multiple critical loci, suggesting high risk for graft-versus-host disease 2

Impact on Autoimmune Disease Predisposition

  • Specific HLA alleles are associated with over 100 different diseases and phenotypes 3
  • HLA typing can provide information about genetic predisposition to autoimmune conditions 4
  • The HLA-DQ locus is particularly important in autoimmune disease associations 4, 3

Technical Considerations in HLA Assessment

  • High-resolution molecular typing is essential for accurate assessment of compatibility 1, 5
  • Both genotypes show allele-level typing, which is more informative than antigen-level typing 1, 5
  • The frequency of specific HLA alleles varies significantly between ethnic groups, which impacts matching probability 1

Recommendations for Transplantation Decision-Making

  • Consider these genotypes as poorly matched for solid organ transplantation, particularly for kidney transplantation 1
  • For kidney transplantation, the HLA-DQ mismatches are especially concerning for long-term outcomes 1
  • For hematopoietic stem cell transplantation, these mismatches would likely require more intensive immunosuppression to prevent rejection 2
  • If transplantation is necessary despite these mismatches, closer monitoring for rejection and DSA development would be warranted 1

Innovative Approaches to Overcome HLA Barriers

  • For patients with rare HLA types, consideration of broader geographic sharing may improve matching 1
  • "Sliding scale" point systems in allocation algorithms can help balance equity and utility for patients with uncommon HLA phenotypes 1
  • Molecular mismatch analysis (epitope matching) may eventually provide more nuanced assessment of compatibility beyond simple allele matching 1

Common Pitfalls in HLA Assessment

  • Focusing only on antigen-level matching rather than allele-level differences (e.g., B44:02 vs. B44:03) 1
  • Neglecting the importance of HLA-DQ matching, which has historically been underemphasized 1
  • Failing to consider both chains of the HLA-DQ molecule (DQA1 and DQB1) when assessing compatibility 1
  • Not accounting for ethnic differences in HLA frequency when interpreting matching probability 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

HLA Genetics for the Human Diseases.

Advances in experimental medicine and biology, 2024

Research

Current research status of HLA in immune-related diseases.

Immunity, inflammation and disease, 2021

Research

HLA testing in the molecular diagnostic laboratory.

Virchows Archiv : an international journal of pathology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.